TY  - JOUR
AU  - Montero Calle, Ana
AU  - Aranguren Abeigon, Itziar
AU  - Garranzo Asensio, María
AU  - Povés Francés, Carmen
AU  - Fernández Aceñero, María Jesús
AU  - Martínez Useros, Javier
AU  - Sanz López, Rodrigo
AU  - Dziakova, Jana
AU  - Rodríguez Cobos, Javier
AU  - Solís Fernández, Guillermo
AU  - Povedano, Eloy
AU  - Gamella Carballo, María
AU  - Torrente Rodríguez, Rebeca Magnolia
AU  - Alonso Navarro, Miren
AU  - Ríos, Vivian de los
AU  - Casal, J. Ignacio
AU  - Domínguez Muñóz, Gemma
AU  - Guzmán Aránguez, Ana Isabel
AU  - Peláez García, Alberto, Alberto
AU  - Pingarrón Carrazón, José Manuel
AU  - Campuzano Ruiz, Susana
AU  - Barderas Manchado, Rodrigo
PY  - 2021
DO  - 10.1016/j.eng.2021.04.026
SN  - 2095-8099; 2096-0026 (e)
UR  - https://hdl.handle.net/20.500.14352/4416
T2  - Engineering
AB  - Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide. The 5-year survival rate of CRC patients depends on the stage at diagnosis, being higher than 80% when CRC is diagnosed in the early stages but lower than 10% when...
LA  - eng
PB  - Elsevier
KW  - Autoantibodies
KW  - Diagnosis
KW  - Colorectal cancer
KW  - Exosomes
KW  - Tumor microenviroment
KW  - Humoral immune response
KW  - Point of care
KW  - Biosensors
TI  - Multiplexed biosensing diagnostic platforms detecting autoantibodies to tumor-associated antigens from exosomes released by CRC cells and tissue samples showed high diagnostic ability for colorectal cancer
TY  - journal article
ER  -